LV

Lalita Vilas Kalel

Active Director Director DIN 07492197
DIN 07492197 First appointment Jun 2016 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2016
Shareholding value •••• Premium profile

About Lalita Vilas Kalel

Data last updated:

Lalita Vilas Kalel is a Director at Sttar Mellison Pharmaceuticals Private Limited (since 2016). The company operates in Pharma. Sttar Mellison Pharmaceuticals Private Limited reported revenue of ₹37.8 Lakh (FY 2025).

DIN 07492197
Primary Designation Director
Industry Pharma
First Appointment 23 Jun 2016
Oldest Company Age 10 yrs
Largest company Sttar Mellison Pharmaceuticals Private Limited · ₹37.8 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director23 Jun 20162016₹37.8 Lakh (FY 2025)Active

Board colleagues of Lalita Vilas Kalel

Directorship timeline

Open interactive timeline →
Sttar Mellison Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Lalita Vilas Kalel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Lalita Vilas Kalel

Lalita Vilas Kalel currently holds 1 directorship: Sttar Mellison Pharmaceuticals Private Limited (Director, since 23 Jun 2016, revenue ₹37.8 Lakh (FY 2025)).

Lalita Vilas Kalel was first appointed on 23 Jun 2016 as Director at Sttar Mellison Pharmaceuticals Private Limited.

The current boards of Lalita Vilas Kalel's companies include Shankar Jagannath Tone (Sttar Mellison Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available